In the most recent trading session, Novavax (NVAX) closed at $6.41, indicating no shift from the previous trading day.

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

COVID-19 booster is here, and public health officials are urging seniors and immunocompromised people to get protected ahead ...

Too easily overlooked are non-influenza, non-COVID viruses and bacteria that are burgeoning and spreading unchecked — both in ...

FRIDAY, May 2, 2025 (HealthDay News) — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. plans to change how ...

Hartford- based Aetna plans to pull out of Affordable Care Act health-insurance exchanges nationwide next year, parent company CVS Health announced on Thursday. "We're disappointed by the continued ...

The market expects ANI Pharmaceuticals (ANIP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus ...

Hartford-based Aetna plans to pull out of Affordable Care Act health-insurance exchanges nationwide next year, parent company CVS Health announced on Thursday. "We're disappointed by the continued ...

The U.S. Health and Human Services Department says it will require placebo testing of "all new vaccines," raising questions ...

Fiverr International (FVRR) concluded the recent trading session at $26.55, signifying a +1.65% move from its prior day's close.